SCHEMBL27797335

SCHEMBL27797335

CCCCc1nc2ccccn2c(=O)c1-c1[c]cccc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
KDM4E B2RXH2 4/20 0.43
TDP1 Q9NUW8 1/20 0.43
AGTR1 P30556 1/20 0.41
AGTR2 P50052 1/20 0.41
ALDH1A1 P00352 2/20 0.38
TP53 P04637 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ADORA3 P0DMS8 2/20 0.37
ADORA1 P30542 2/20 0.37
POLB P06746 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ADORA2A P29274 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27776487 0.85 MAPT (0.39) MAPTKDM4EALDH1A1TP53SMN1; SMN2
SCHEMBL27797299 0.84 FADS1 (0.36) MAPTKDM4ETDP1AGTR1AGTR2
SCHEMBL5129012 0.82 MAPT (0.53) MAPTKDM4ETDP1AGTR1AGTR2
SCHEMBL27776485 0.80 MAPT (0.50) MAPTKDM4ETDP1AGTR1AGTR2
SCHEMBL3953186 0.78 MAPT (0.59) MAPTKDM4ETDP1AGTR1AGTR2
SCHEMBL3955434 0.78 MAPT (0.53) MAPTKDM4ETDP1AGTR1AGTR2
SCHEMBL3959308 0.78 MAPT (0.53) MAPTKDM4ETDP1AGTR1AGTR2
SCHEMBL3961340 0.78 MAPT (0.53) MAPTKDM4ETDP1AGTR1AGTR2
SCHEMBL3959035 0.76 MAPT (0.60) MAPTKDM4ETDP1AGTR1AGTR2
SCHEMBL3959990 0.76 MAPT (0.51) MAPTKDM4ETDP1AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101636398-A Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions XENON PHARMACEUTICALS INC 2010-01-27 CN claimed
CN-101636398-A Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions XENON PHARMACEUTICALS INC 2010-01-27 CN disclosed